Business News • PR NewsWire • Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

GAITHERSBURG, Md. and SUZHOU, China, July 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company has received regulatory...

View More : https://www.prnewswire.com:443/news-releases/sirnaomics-receives-ind-clearance-from-the-taiwan-ministry-of-health-and-we...

Releted News by prnewswire

Yamaha and Tomplay start partnership to transform musicians' daily practice into a unique experience

CONCENTRIC INTERIM REPORT JANUARY - JUNE 2022

BSV BLOCKCHAIN ASSOCIATION PARTNERS WITH TIMECHAIN LABS TO HOST BLOCKCHAIN EVENT IN INDIA

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

LG Innotek Releases 2022 2nd Quarter Earnings Report

Aquark entwickelt InverPad® Turbo Tech zur Reduzierung der Geräuschemissionen von Poolwärmepumpen

Driver Monitoring Systems Shipments Will Jump 487.5% Between 2022 and 2027, Increasing Safety and Creating a Lucrative Monetization Opportunity for Carmakers